Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?
The demand for parenchyma-sparing local therapies for lung cancer is rising owing to an increasing incidence of multifocal lung cancers and patients who are unfit for surgery. With the latest evidence of the efficacy of lung cancer screening, more premalignant or early-stage lung cancers are being d...
Gespeichert in:
Veröffentlicht in: | Cancers 2023-02, Vol.15 (4), p.1068 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 4 |
container_start_page | 1068 |
container_title | Cancers |
container_volume | 15 |
creator | Chan, Joyce W Y Siu, Ivan C H Chang, Aliss T C Li, Molly S C Lau, Rainbow W H Mok, Tony S K Ng, Calvin S H |
description | The demand for parenchyma-sparing local therapies for lung cancer is rising owing to an increasing incidence of multifocal lung cancers and patients who are unfit for surgery. With the latest evidence of the efficacy of lung cancer screening, more premalignant or early-stage lung cancers are being discovered and the paradigm has shifted from treatment to prevention. Transbronchial therapy is an important armamentarium in the local treatment of lung cancers, with microwave ablation being the most promising based on early to midterm results. Adjuncts to improve transbronchial ablation efficiency and accuracy include mobile C-arm platforms, software to correct for the CT-to-body divergence, metal-containing nanoparticles, and robotic bronchoscopy. Other forms of energy including steam vapor therapy and pulse electric field are under intensive investigation. |
doi_str_mv | 10.3390/cancers15041068 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9954491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A743010048</galeid><sourcerecordid>A743010048</sourcerecordid><originalsourceid>FETCH-LOGICAL-c488t-a54c3f092d36d7680f2477c603efadfe60fdb8dcf1f5a64d25531e1e028d43b73</originalsourceid><addsrcrecordid>eNptkcFvFCEUxonR2Kb27M1M4sXLto-BAcaDZrOx1WSjlzU9EhYeuzQzUGGnxv9etq3NthFCHoHf-x6Pj5C3FM4Y6-HcmmgxF9oBpyDUC3LcgmxnQvT85cH-iJyWcg11MEalkK_JEROKUU7pMblYZRPLOqdot8EMzQrtNoZfE5bGp9wsp7hpFnd1mlVGsxsx7j42V1vM2MzrusLme_r9-Q155c1Q8PQhnpCfF19Wi6-z5Y_Lb4v5cma5UruZ6bhlHvrWMeGkUOBbLqUVwNAb51GAd2vlrKe-M4K7tusYRYrQKsfZWrIT8ule92Zaj-hsfU02g77JYTT5j04m6Kc3MWz1Jt3qvu8472kV-PAgkNO-y50eQ7E4DCZimopupQKQjKu-ou-foddpyrG2VynZ8w7oIbUxA-oQfap17V5UzyVnQAG4qtTZf6g6HY7Bpog-1PMnCef3CTanUjL6xx4p6L37-pn7NePd4dc88v-8Zn8Bpr6p6w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2779450189</pqid></control><display><type>article</type><title>Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Chan, Joyce W Y ; Siu, Ivan C H ; Chang, Aliss T C ; Li, Molly S C ; Lau, Rainbow W H ; Mok, Tony S K ; Ng, Calvin S H</creator><creatorcontrib>Chan, Joyce W Y ; Siu, Ivan C H ; Chang, Aliss T C ; Li, Molly S C ; Lau, Rainbow W H ; Mok, Tony S K ; Ng, Calvin S H</creatorcontrib><description>The demand for parenchyma-sparing local therapies for lung cancer is rising owing to an increasing incidence of multifocal lung cancers and patients who are unfit for surgery. With the latest evidence of the efficacy of lung cancer screening, more premalignant or early-stage lung cancers are being discovered and the paradigm has shifted from treatment to prevention. Transbronchial therapy is an important armamentarium in the local treatment of lung cancers, with microwave ablation being the most promising based on early to midterm results. Adjuncts to improve transbronchial ablation efficiency and accuracy include mobile C-arm platforms, software to correct for the CT-to-body divergence, metal-containing nanoparticles, and robotic bronchoscopy. Other forms of energy including steam vapor therapy and pulse electric field are under intensive investigation.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers15041068</identifier><identifier>PMID: 36831411</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Ablation ; Biopsy ; Bronchoscopy ; Cancer ; Cancer screening ; Cancer therapies ; Care and treatment ; Catheters ; Disease prevention ; Fistula ; Hemoptysis ; Lung cancer ; Medical imaging ; Medical screening ; Medical technology ; Mortality ; Nanoparticles ; Parenchyma ; Patients ; Pleural effusion ; Pneumothorax ; Radiation ; Radiation therapy ; Review ; Risk groups ; Surgery ; Surgical outcomes ; Thoracic surgery ; Tumors</subject><ispartof>Cancers, 2023-02, Vol.15 (4), p.1068</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c488t-a54c3f092d36d7680f2477c603efadfe60fdb8dcf1f5a64d25531e1e028d43b73</citedby><cites>FETCH-LOGICAL-c488t-a54c3f092d36d7680f2477c603efadfe60fdb8dcf1f5a64d25531e1e028d43b73</cites><orcidid>0000-0002-8074-0900 ; 0000-0002-7276-9172</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954491/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954491/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36831411$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, Joyce W Y</creatorcontrib><creatorcontrib>Siu, Ivan C H</creatorcontrib><creatorcontrib>Chang, Aliss T C</creatorcontrib><creatorcontrib>Li, Molly S C</creatorcontrib><creatorcontrib>Lau, Rainbow W H</creatorcontrib><creatorcontrib>Mok, Tony S K</creatorcontrib><creatorcontrib>Ng, Calvin S H</creatorcontrib><title>Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>The demand for parenchyma-sparing local therapies for lung cancer is rising owing to an increasing incidence of multifocal lung cancers and patients who are unfit for surgery. With the latest evidence of the efficacy of lung cancer screening, more premalignant or early-stage lung cancers are being discovered and the paradigm has shifted from treatment to prevention. Transbronchial therapy is an important armamentarium in the local treatment of lung cancers, with microwave ablation being the most promising based on early to midterm results. Adjuncts to improve transbronchial ablation efficiency and accuracy include mobile C-arm platforms, software to correct for the CT-to-body divergence, metal-containing nanoparticles, and robotic bronchoscopy. Other forms of energy including steam vapor therapy and pulse electric field are under intensive investigation.</description><subject>Ablation</subject><subject>Biopsy</subject><subject>Bronchoscopy</subject><subject>Cancer</subject><subject>Cancer screening</subject><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Catheters</subject><subject>Disease prevention</subject><subject>Fistula</subject><subject>Hemoptysis</subject><subject>Lung cancer</subject><subject>Medical imaging</subject><subject>Medical screening</subject><subject>Medical technology</subject><subject>Mortality</subject><subject>Nanoparticles</subject><subject>Parenchyma</subject><subject>Patients</subject><subject>Pleural effusion</subject><subject>Pneumothorax</subject><subject>Radiation</subject><subject>Radiation therapy</subject><subject>Review</subject><subject>Risk groups</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Thoracic surgery</subject><subject>Tumors</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkcFvFCEUxonR2Kb27M1M4sXLto-BAcaDZrOx1WSjlzU9EhYeuzQzUGGnxv9etq3NthFCHoHf-x6Pj5C3FM4Y6-HcmmgxF9oBpyDUC3LcgmxnQvT85cH-iJyWcg11MEalkK_JEROKUU7pMblYZRPLOqdot8EMzQrtNoZfE5bGp9wsp7hpFnd1mlVGsxsx7j42V1vM2MzrusLme_r9-Q155c1Q8PQhnpCfF19Wi6-z5Y_Lb4v5cma5UruZ6bhlHvrWMeGkUOBbLqUVwNAb51GAd2vlrKe-M4K7tusYRYrQKsfZWrIT8ule92Zaj-hsfU02g77JYTT5j04m6Kc3MWz1Jt3qvu8472kV-PAgkNO-y50eQ7E4DCZimopupQKQjKu-ou-foddpyrG2VynZ8w7oIbUxA-oQfap17V5UzyVnQAG4qtTZf6g6HY7Bpog-1PMnCef3CTanUjL6xx4p6L37-pn7NePd4dc88v-8Zn8Bpr6p6w</recordid><startdate>20230208</startdate><enddate>20230208</enddate><creator>Chan, Joyce W Y</creator><creator>Siu, Ivan C H</creator><creator>Chang, Aliss T C</creator><creator>Li, Molly S C</creator><creator>Lau, Rainbow W H</creator><creator>Mok, Tony S K</creator><creator>Ng, Calvin S H</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8074-0900</orcidid><orcidid>https://orcid.org/0000-0002-7276-9172</orcidid></search><sort><creationdate>20230208</creationdate><title>Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?</title><author>Chan, Joyce W Y ; Siu, Ivan C H ; Chang, Aliss T C ; Li, Molly S C ; Lau, Rainbow W H ; Mok, Tony S K ; Ng, Calvin S H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c488t-a54c3f092d36d7680f2477c603efadfe60fdb8dcf1f5a64d25531e1e028d43b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Ablation</topic><topic>Biopsy</topic><topic>Bronchoscopy</topic><topic>Cancer</topic><topic>Cancer screening</topic><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Catheters</topic><topic>Disease prevention</topic><topic>Fistula</topic><topic>Hemoptysis</topic><topic>Lung cancer</topic><topic>Medical imaging</topic><topic>Medical screening</topic><topic>Medical technology</topic><topic>Mortality</topic><topic>Nanoparticles</topic><topic>Parenchyma</topic><topic>Patients</topic><topic>Pleural effusion</topic><topic>Pneumothorax</topic><topic>Radiation</topic><topic>Radiation therapy</topic><topic>Review</topic><topic>Risk groups</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Thoracic surgery</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, Joyce W Y</creatorcontrib><creatorcontrib>Siu, Ivan C H</creatorcontrib><creatorcontrib>Chang, Aliss T C</creatorcontrib><creatorcontrib>Li, Molly S C</creatorcontrib><creatorcontrib>Lau, Rainbow W H</creatorcontrib><creatorcontrib>Mok, Tony S K</creatorcontrib><creatorcontrib>Ng, Calvin S H</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, Joyce W Y</au><au>Siu, Ivan C H</au><au>Chang, Aliss T C</au><au>Li, Molly S C</au><au>Lau, Rainbow W H</au><au>Mok, Tony S K</au><au>Ng, Calvin S H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2023-02-08</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><spage>1068</spage><pages>1068-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>The demand for parenchyma-sparing local therapies for lung cancer is rising owing to an increasing incidence of multifocal lung cancers and patients who are unfit for surgery. With the latest evidence of the efficacy of lung cancer screening, more premalignant or early-stage lung cancers are being discovered and the paradigm has shifted from treatment to prevention. Transbronchial therapy is an important armamentarium in the local treatment of lung cancers, with microwave ablation being the most promising based on early to midterm results. Adjuncts to improve transbronchial ablation efficiency and accuracy include mobile C-arm platforms, software to correct for the CT-to-body divergence, metal-containing nanoparticles, and robotic bronchoscopy. Other forms of energy including steam vapor therapy and pulse electric field are under intensive investigation.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36831411</pmid><doi>10.3390/cancers15041068</doi><orcidid>https://orcid.org/0000-0002-8074-0900</orcidid><orcidid>https://orcid.org/0000-0002-7276-9172</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6694 |
ispartof | Cancers, 2023-02, Vol.15 (4), p.1068 |
issn | 2072-6694 2072-6694 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9954491 |
source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
subjects | Ablation Biopsy Bronchoscopy Cancer Cancer screening Cancer therapies Care and treatment Catheters Disease prevention Fistula Hemoptysis Lung cancer Medical imaging Medical screening Medical technology Mortality Nanoparticles Parenchyma Patients Pleural effusion Pneumothorax Radiation Radiation therapy Review Risk groups Surgery Surgical outcomes Thoracic surgery Tumors |
title | Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T07%3A55%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transbronchial%20Techniques%20for%20Lung%20Cancer%20Treatment:%20Where%20Are%20We%20Now?&rft.jtitle=Cancers&rft.au=Chan,%20Joyce%20W%20Y&rft.date=2023-02-08&rft.volume=15&rft.issue=4&rft.spage=1068&rft.pages=1068-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers15041068&rft_dat=%3Cgale_pubme%3EA743010048%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2779450189&rft_id=info:pmid/36831411&rft_galeid=A743010048&rfr_iscdi=true |